SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-24-041264
Filing Date
2024-04-03
Accepted
2024-04-03 17:10:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A 2024_schedule_13da_-_lar.htm SC 13D/A 58216
  Complete submission text file 0000950170-24-041264.txt   59552
Mailing Address C/O REXAHN PHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address
Sullivan Lara (Filed by) CIK: 0001769457 (see all company filings)

Type: SC 13D/A

Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Subject) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92951 | Film No.: 24819950
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)